Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Clinical trial NCT01091103 · COMPLETED

Trial details

NCT number: NCT01091103
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Progressive Castration-resistant Prostate Cancer

Start date: 2010-02-18
Primary completion: 2012-02-29
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.